SCHEMBL16057661

SCHEMBL16057661

Cc1cc(-c2ccnc(OC(=O)O)c2C)ccc1-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC2A1 P11166 1/20 0.42
▸ ESR2 Q92731 1/20 0.41
▸ EPHX1 P07099 1/20 0.39
▸ PPARG P37231 1/20 0.38
▸ PPARA Q07869 1/20 0.38
▸ PDE3B Q13370 1/20 0.38
▸ PDE3A Q14432 1/20 0.38
▸ SQOR Q9Y6N5 1/20 0.37
▸ PORCN Q9H237 1/20 0.36
▸ LDHA P00338 1/20 0.36
▸ LRRK2 Q5S007 1/20 0.36
▸ WNT3A P56704 1/20 0.36
▸ MCL1 Q07820 1/20 0.35
▸ BACE1 P56817 1/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16056701 0.91 KMO (0.41) SLC2A1LDHALRRK2MEN1KMT2A
SCHEMBL16057029 0.91 KDM5A (0.40) SLC2A1PPARGPPARAMCL1KDM5A
SCHEMBL14975894 0.89 PORCN (0.40) EPHX1SQORPORCNBACE1MEN1
SCHEMBL16056981 0.88 SLC6A7 (0.41) EPHX1PPARGPPARAMCL1RAB9A
SCHEMBL16058727 0.88 PTGS1 (0.41) MEN1KMT2ACYP1A2CYP2C9CYP2C19
SCHEMBL16058355 0.85 PORCN (0.41) EPHX1SQORPORCNWNT3AMEN1
SCHEMBL16057338 0.82 KMO (0.44) PPARGPPARAPORCNWNT3AMEN1
SCHEMBL16057040 0.82 RAB9A (0.44) MEN1KMT2ARAB9AALDH1A1
SCHEMBL16057423 0.81 CCNC (0.39) EPHX1PORCNMEN1KMT2APIK3CA
SCHEMBL16058685 0.81 LMNA (0.39) EPHX1MEN1KMT2ARAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9828338-B2 Carbamate derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-11-28 — — US disclosed
US-20160068482-A1 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2016-03-10 — — US disclosed
WO-2014144836-A2 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-09-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160068482-A1 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS NAAA, FAAH, FAAH2 SLC2A1 4218/4885ESR2 1888/4885EPHX1 222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback